查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1844147

乳房超音波市场按产品类型、模式、技术、探头类型、应用和最终用户划分－2025-2032年全球预测

Breast Ultrasound Market by Product, Modality, Technology, Transducer Type, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，乳房超音波市场规模将达到 73.3 亿美元，复合年增长率为 10.96%。

主要市场统计数据
基准年 2024 31.9亿美元
预计年份：2025年 35.4亿美元
预测年份：2032年 73.3亿美元
复合年增长率 (%) 10.96%

本文概述了乳房超音波在临床、技术和政策方面的演变，并重点介绍了变革的驱动因素和相关人员。

在影像物理学、探头设计和临床通讯协定的同步进步推动下，乳房超音波已从一种辅助手段转变为现代乳房诊疗流程中不可或缺的一部分。随着筛检模式的演变和个人化诊断策略的普及，超音波在病灶定性、标靶切片检查和即时介入指导方面发挥越来越重要的作用。这种转变提升了超音波在门诊、影像中心、日间手术中心和医院乳房计画中的重要性，并创造了临床需求与市场创新之间的新交汇点。

同时，科技的普及加速了可携式和手持式系统的采用，使得在非传统环境下进行照护现场评估成为可能，并改善了资源匮乏地区的医疗服务可及性。这种扩张给传统的采购模式、服务合约和培训计划带来了压力，迫使临床领导者重新思考生命週期管理和整体拥有成本。此外，监管机构和支付方也积极回应多机构研究和临床实务指南中涌现的证据，从而影响各机构的采购重点和资金配置。将技术、临床和政策因素综合起来，有助于相关人员权衡短期利弊，并将投资与长期临床目标保持一致。

分析乳房超音波技术、临床路径和劳动力发展的变革性变化，这些变化正在重新定义病患路径和诊断方法。

乳房超音波领域正经历着一场变革性的转变，这场变革正在重塑临床工作流程、设备设计和企业策略。人工智慧和先进的影像处理正被整合到影像撷取和解读阶段，以实现病灶的智慧检测、自动测量和标准化报告。这些功能正在改变技师和放射科医生的角色，提高诊疗效率，同时降低技师间的差异，并支持以指标为导向的品质保证系统。同时，弹性成像和造影超音波正在增强病灶鑑别诊断的信心，并且在循证医学规范的通讯协定下合理应用，可以减少对侵入性检查的依赖。

同时，手持式和照护现场系统的多样化正在扩大医疗服务的覆盖范围，分散医疗服务，并推动培训模式和资格认证的转变。电池供电的手持设备和有线手持设备使临床医生能够在床边或社区诊所进行检测，从而减轻患者的出行负担并加快诊断速度。在供应方面，模组化设备架构和探头互换性提高了可维护性，并使医疗机构能够逐步扩展其功能。这些技术和临床方面的转变要求医疗服务提供者、支付方和医疗设备製造商在培训、检验测试和报销机制方面开展合作，以确保技术创新能够转化为诊断准确性和以患者为中心的疗效方面的可衡量改进。

对美国关税趋势直至2025年及其对医疗保健机构运营、供应链和采购的影响进行全面评估

美国在2025年前实施的累积关税措施，对乳房超音波生态系统内的采购、库存管理和供应商选择决策产生了多方面的影响。对关键零件和成品设备征收的关税增加了直接进口成本，促使采购商重新评估其供应商组合，并在可行的情况下优先考虑在地采购生产和区域性生产。这些变化促使设备製造商重新评估其生产布局，加快近岸外包和双重采购策略，并重新谈判交易条款以缓解成本压力。对于医院和影像中心而言，资本规划也变得更加复杂，因为采购团队必须权衡短期价格波动与对供应商的长期策略承诺。

除了设备本身的价格之外，关税主导的成本上涨还会波及耗材和服务组件，改变探头、凝胶、无菌套和维护合约的经济效益。医疗机构可能会透过更积极主动的预防性保养来延长设备的使用寿命，或改用替代耗材，或透过集中采购来享受批量折扣。同时，製造商和经销商正在优先考虑供应链的韧性，投资于冗余物流、关税分类优化和合约保护。监管合规和文件要求日益严格，迫使采购和临床工程团队密切合作，以检验产品来源、澄清海关问题并规划库存缓衝，从而在不造成存量基准的情况下维持临床服务的连续性。关税环境的累积正在加速乳房超音波系统及其辅助产品的供应商多元化、合约弹性和全生命週期成本分析等方面的策略规划。

详细的细分洞察，将产品、模式、技术、感测器类型、应用和最终用户趋势与临床和采购优先事项联繫起来。

准确的细分资讯揭示了需求和决策驱动因素如何因产品、模式、技术、换能器类型、应用和最终用户领域而异。在产品细分中，配件和耗材包括凝胶和无菌套等物品，这些物品会影响每次检查的成本和感染控制流程；设备包括探头和系统，其中探头的选择直接影响图像保真度和应用适用性；服务包括安装、维护和培训，这些服务有助于提高运作和用户熟练度。这些产品细分透过使耗材选择和服务水准与买方期望的吞吐量和品质目标相匹配，从而影响采购週期和合约谈判。

模态划分区分了推车/手推车系统和手持设备；推车/手推车系统又进一步细分为可携式推车和适用于固定场所或半移动式工作流程的推车式设备，而手持设备则分为电池供电型和有线型，前者优先考虑便携性和持续临床使用。技术划分凸显了二维超音波的持续重要性，同时三维/四维成像、多普勒和弹性成像技术也日益普及，每种技术在病灶检测、血管评估和组织硬度表征方面都具有独特的诊断价值。探头的选择对临床表现至关重要，因为探头的形态和频率特性决定了解析度和穿透深度。

应用细分将诊断和介入应用场景区分开来。诊断应用进一步包括病灶特征分析、筛检和分期，这些应用情境的影像处理通讯协定和报告标准各不相同。介入应用包括穿刺、切片检查引导和引流，这些应用情境对即时视觉化和无菌耗材的要求很高。最后，最终用户细分涵盖门诊手术中心、诊所、影像中心和医院，每个机构的资金来源、资金限制和人员配置模式都各不相同。整合这些细分层级，使相关人员能够将技术能力和服务组合与临床目标和实际营运情况相匹配，从而优化临床疗效和资金效率。

关键区域洞察：比较主要全球区域的采用模式、监管环境、报销差异和基础设施准备情况

区域动态对全球乳房超音波的普及模式、监管环境、报销模式和基础设施建设有显着影响。在美洲，完善的筛检计画和成熟的医院体系推动了对先进影像处理技术和可靠服务协议的需求。该地区的监管合规性和支付方的积极参与，使得清晰的临床证据和标准化的报告流程成为可能，这为能够证明其可重复获益并提供综合培训项目的供应商创造了机会。

欧洲、中东和非洲在市场成熟度和基础设施能力方面存在差异。西欧的系统着重于互通性、品质保证以及与多学科乳腺诊疗路径的整合，而中东和非洲部分地区则优先考虑可及性、可负担性和维护支持。这种差异性要求制定适应性强的商业化策略和灵活的服务模式。在亚太地区，可携式手持系统的快速普及与城市中心对高阶平台的大力投资并存。在所有地区，监管协调、人才培养和明确的报销机制仍然是推动技术进步转化为更完善的诊断流程和更广泛可及性的关键因素。

针对主要企业的竞争格局、联盟、研发重点和商业化路径进行竞争考察

乳房超音波领域的竞争者们正透过整合解决方案、卓越服务和有针对性的临床检验来实现差异化竞争。领先企业致力于将硬体创新与软体生态系统融合，并寻求将先进的换能器设计与人工智慧主导的影像分析、云端病例管理和报告标准化相结合的伙伴关係。此类合作透过降低整合负担，并更清晰地展示诊断和介入应用中的临床效用，从而加快客户实现价值的速度。

商业策略正日益重视全生命週期合作，而非一次性设备销售。提供安装、客製化培训和以结果为导向的服务合约的公司正在加强与医疗系统的长期合作关係。同时，中型和新兴供应商正利用其灵活性进入尚未开发的细分市场，通常凭藉诸如专用探头或优化工作流程的手持设备等利基功能展开竞争。研发投资的重点在于探头小型化、改进讯号处理以及降低对操作人员依赖性的使用者介面。策略併购和经销协议仍是加速地域扩张和填补产品系列空白的有效手段。此外，在运作和反应迅速的技术支援是影响购买决策的关键因素的市场中，拥有强大的本地服务网路的公司更具优势。

为产业领导者提供切实可行的优先建议，以提升医疗设备的可及性、优化临床工作流程、增强供应商韧性并促进支付方参与。

产业领导者应采用切实可行的策略，将技术选择与临床目标、供应链韧性和可持续的成本管理相结合。这包括协商透明的服务等级协议，并确保备件和耗材的明确规定，以避免下游价格波动。其次，投资于标准化的培训和资格认证项目，将提高使用者熟练程度，降低测试表现的差异性，并支持与诊断率相关的内部品质指标。第三，实现供应商关係多元化，以降低关税和物流风险，并建立灵活的合约机制，以便在出现供应中断时能够产量比率进行替代或本地采购。

此外，各机构应在受控环境下试行人工智慧和工作流程自动化，以检验临床影响并获得临床医生的认可，然后再进行规模化应用。儘早与支付方接洽，记录价值路径，并探索能够评估时间节省、下游流程简化和诊断分诊改善的报销机制。对于製造商而言，提供模组化升级方案、透明的维护模式和耗材捆绑销售可以提高对资金受限买家的吸引力。最后，应实施跨职能管治，包括临床领导、采购和生物医学工程部门，以确保在采购、部署和持续绩效监控过程中决策的一致性。这些措施的结合可以增强应对技术发展和政策主导的市场变化的能力。

透明的调查方法，描述了资料来源、检验通讯协定、专家咨询以及应用于乳房超音波分析的分析严谨性。

本分析的调查方法结合了专家的直接参与和严格的二次检验，以确保结论既反映一线临床经验，也反映更广泛的行业讯号。主要资讯来源包括对放射科医生、超音波、临床工程专家、采购负责人和企业策略家的结构化访谈，以深入了解设备利用率、培训缺口和供应商绩效。二次验证包括收集同行评审文献、官方监管指南、产品技术文件和临床试验结果，以检验有关诊断性能和技术成熟度的论点。在可能的情况下，所有论点均透过多个独立资讯来源进行核实，以最大限度地减少单一资讯来源偏差。

透过一套记录在案的检验通讯协定，包括最后覆核、产品和感测器分类的一致性以及服务和耗材分类的协调，确保了分析的严谨性。专家咨询提供了对区域监管细微差别和支付方动态的深入了解。限制包括各机构报告标准的差异以及软体功能的快速发展，这些发展速度可能超过已发表的检验研究。为了克服这些限制，调查方法强调透明的假设、对资讯来源的审核以及迭代审查週期，在综合建议时优先考虑高品质的临床证据和实际操作情况。

总结了旨在提高诊断准确性和改善患者预后的策略性建议，这些建议对临床医生、管理者和製造商都有指导意义。

综合分析表明，乳房超音波正处于曲折点，技术进步、临床管道变革和外部政策因素正在交汇融合，再形成其应用和采购行为。人工智慧的整合、弹性成像和造影技术的日益普及以及携带式超音波设备的引入，拓宽了超音波的临床效用范围，同时也对培训、检验和服务体系提出了新的要求。同时，政策和价格压力将进一步影响筹资策略和成本结构，促使相关人员采取更灵活的采购和供应商管理方式。

对临床医师而言，主要意义在于重新聚焦于标准化采购通讯协定、品质保证以及跨专业协作，以充分发挥新技术在诊断方面的优势。对于管理者和采购人员而言，应专注于灵活的合约谈判，充分考虑耗材流通、维护需求以及关税相关的潜在成本压力。对于製造商而言，提供可互通的软硬体生态系统、可验证的临床价值以及可靠的服务网络是成功的关键。透过将技术选择与营运能力和实证临床目标结合，相关人员可以提高诊断准确性、简化工作流程，并最终改善不同医疗环境中患者的治疗效果。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 采用造影超音波技术来改善乳房病灶的定性
  • 增加自动化系统的使用，以提高緻密乳房组织的筛检敏感性
  • 超音波设备弹性成像技术的进步可更准确地评估乳房摄影中的组织硬度
  • 门诊照护现场诊断对可携式和手持式乳房超音波扫描仪的需求日益增长
  • 开发一种结合临床数据和超音波影像指标的AI驱动风险分层工具，用于个人化乳癌筛检
  • 拓展远端超音波服务，以实现乳癌诊断领域专家之间的远端判读和协作。

第六章美国关税的累积影响，2025年

第七章 人工智慧的累积影响，2025年

第八章 乳房超音波市场：依产品分类

  • 配件和耗材
    • 凝胶
    • 无菌盖
  • 装置
    • 探测
    • 系统
  • 服务
    • 安装
    • 维护
    • 训练

第九章 乳房超音波市场：依模式划分

  • 手推车/平板车
    • 可携式推车
    • 手推车式支架
  • 手持式
    • 电池供电
    • 繫绳类型

第十章 乳房超音波市场：依技术分类

  • 二维超音波
  • 3D/4D超音波
  • 多普勒超音波
  • 弹性成像

第十一章 以换能器类型分類的乳房超音波市场

  • 3D感测器
  • 曲线阵列
  • 线性阵列
  • 相位阵列

第十二章 乳房超音波市场：依应用领域划分

  • 诊断
    • 病变特征
    • 筛检
    • 舞台
  • 干涉
    • 吸
    • 切片检查引导
    • 引流

第十三章 乳房超音波市场（依最终用户划分）

  • 门诊手术中心
  • 诊所
  • 诊断影像中心
  • 医院

第十四章 各地区乳房超音波市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章 乳房超音波市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章 各国乳房超音波市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • GE HealthCare Technologies Inc.
    • Siemens Healthineers AG
    • Koninklijke Philips NV
    • Hologic, Inc.
    • Canon Medical Systems Corporation
    • Samsung Medison Co., Ltd.
    • Fujifilm Holdings Corporation
    • Hitachi, Ltd.
    • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • Shenzhen SonoScape Medical Corp.
Product Code: MRR-ED54C46E81B4

The Breast Ultrasound Market is projected to grow by USD 7.33 billion at a CAGR of 10.96% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 3.19 billion
Estimated Year [2025] USD 3.54 billion
Forecast Year [2032] USD 7.33 billion
CAGR (%) 10.96%

Introduction framing the evolving clinical, technological, and policy context for breast ultrasound, highlighting drivers of change and stakeholder priorities

Breast ultrasound has moved from a largely adjunct modality to an essential component of modern breast care pathways, driven by simultaneous advances in imaging physics, transducer design, and clinical protocols. As screening paradigms evolve and personalized diagnostic strategies take hold, ultrasound increasingly supports lesion characterization, targeted biopsies, and real-time interventional guidance. These shifts amplify the modality's relevance across outpatient clinics, diagnostic imaging centers, ambulatory surgical facilities, and hospital-based breast programs, creating new intersections between clinical need and market innovation.

In parallel, technology diffusion has accelerated adoption of portable and handheld systems, enabling point-of-care assessments in nontraditional settings and improving access in resource-constrained environments. This expansion creates pressure on traditional procurement models, service contracts, and training initiatives, requiring clinical leaders to rethink lifecycle management and total cost of ownership. Moreover, regulatory and payer landscapes are responding to evidence from multicenter studies and practice guidelines, which in turn influences purchasing priorities and capital allocation across institutions. By framing the technical, clinical, and policy elements together, stakeholders can better navigate near-term tradeoffs and align investments with long-term clinical objectives.

Analysis of transformative shifts in breast ultrasound technology, clinical pathways, and workforce training that are redefining patient pathways and diagnostics

The breast ultrasound landscape is undergoing transformative shifts that are reshaping clinical workflows, device design, and enterprise strategies. Artificial intelligence and advanced image processing are integrating into acquisition and interpretation stages, augmenting lesion detection, automating measurements, and supporting standardized reporting. These capabilities are changing the role of the technologist and the radiologist, accelerating throughput while reducing inter-operator variability, and enabling metrics-driven quality assurance programs. Concurrently, elastography and contrast-enhanced ultrasound are expanding diagnostic confidence for lesion characterization, reducing reliance on more invasive procedures when used judiciously within evidence-based protocols.

At the same time, modality diversification toward handheld and point-of-care systems expands access and decentralizes care, prompting shifts in training models and credentialing. Battery-powered handheld devices and tethered handheld options enable clinicians to perform exams at the bedside or in community clinics, which reduces patient travel burden and shortens time-to-diagnosis. On the supply side, modular equipment architectures and probe interchangeability improve serviceability and allow institutions to scale capabilities gradually. Together, these technological and clinical shifts demand that providers, payers, and manufacturers collaborate on training, validation studies, and reimbursement mechanisms to ensure innovations translate into measurable improvements in diagnostic accuracy and patient-centered outcomes.

Comprehensive assessment of United States tariff developments by 2025 and their operational, supply chain, and procurement implications for healthcare providers

Cumulative tariff actions introduced by the United States through 2025 have created multilayered effects across procurement, inventory management, and vendor sourcing decisions within the breast ultrasound ecosystem. Tariffs applied to key components and finished devices increase direct import costs, prompting buyers to re-evaluate supplier portfolios and prioritize local content or regional manufacturing where feasible. This dynamic encourages device makers to reassess production footprints, accelerate nearshoring or dual-sourcing strategies, and renegotiate commercial terms to mitigate cost pressure. For hospitals and imaging centers, it also complicates capital planning as procurement teams must weigh short-term price volatility against long-term strategic commitments to vendors.

Beyond direct device pricing, tariff-driven cost increases ripple into consumables and service components, altering the economics of probes, gels, sterile covers, and maintenance agreements. Providers may respond by extending service life through more aggressive preventative maintenance, shifting to alternative consumables, or consolidating purchases to leverage volume discounts. In turn, manufacturers and distributors focus on supply chain resilience, investing in redundant logistics, tariff classification optimization, and contractual protections. Regulatory compliance and documentation requirements tighten, requiring procurement and clinical engineering teams to collaborate closely to validate origin, ensure customs clarity, and plan inventory buffers that maintain clinical continuity without overstating stock levels. Ultimately, the cumulative tariff environment has accelerated strategic planning around supplier diversification, contract flexibility, and total lifecycle cost analysis for breast ultrasound systems and ancillary products.

In-depth segmentation insights that map product, modality, technology, transducer type, application, and end user trends to clinical and procurement priorities

Accurate segmentation intelligence clarifies how demand and decision drivers vary across product, modality, technology, transducer type, application, and end user domains. Within product segmentation, Accessories & Consumables comprise items such as gel and sterile covers that influence per-exam costs and infection control workflows; Equipment spans probes and systems where probe selection directly affects image fidelity and application suitability; and Services include installation, maintenance, and training that underpin uptime and user proficiency. These product distinctions shape procurement cycles and contract negotiations, as buyers align consumable choices and service levels to desired throughput and quality targets.

Modality segmentation distinguishes cart/trolley systems from handheld devices, with the cart/trolley category further splitting into portable cart and trolley mounted options that suit fixed-site or semi-mobile workflows, while handheld options divide into battery powered and tethered models that prioritize portability versus sustained clinical use. Technology segmentation highlights the persistent relevance of 2D ultrasound alongside growing adoption of 3D/4D imaging, Doppler modalities, and elastography, each contributing distinct diagnostic value for lesion detection, vascular assessment, and tissue stiffness characterization. Transducer type segmentation encompasses 3D transducers, curved array, linear array, and phased array probes; probe geometry and frequency profiles determine resolution and penetration, making transducer choice central to clinical performance.

Application segmentation separates diagnostic and interventional use cases. Diagnostic applications further include lesion characterization, screening, and staging, where imaging protocols and reporting standards differ; interventional applications include aspiration, biopsy guidance, and drainage, where real-time visualization and sterile consumables are critical. Lastly, end user segmentation spans ambulatory surgical centers, clinics, diagnostic imaging centers, and hospitals, each with distinct procurement levers, capital constraints, and staffing models. By synthesizing these segment layers, stakeholders can match technology features and service bundles to clinical objectives and operational realities, optimizing both clinical outcomes and procurement efficiency.

Key regional insights that compare adoption patterns, regulatory landscapes, reimbursement variances, and infrastructure readiness across core global regions

Regional dynamics exert a strong influence on adoption patterns, regulatory frameworks, reimbursement models, and infrastructure readiness across the global breast ultrasound landscape. In the Americas, established screening programs and a mature hospital sector drive demand for advanced imaging features and robust service agreements, while private clinics increasingly adopt handheld devices for point-of-care applications. Regulatory conformity and payer engagement in this region tend to favor clear clinical evidence and standardized reporting workflows, creating opportunities for vendors that can demonstrate reproducible benefits and offer integrated training programs.

Europe, Middle East & Africa present a heterogeneous mix of market maturity and infrastructure capabilities, with Western European systems focused on interoperability, quality assurance, and integration into multidisciplinary breast care pathways, while parts of the Middle East and Africa prioritize access, affordability, and maintenance support. This heterogeneity requires adaptable commercialization strategies and flexible service models. In the Asia-Pacific region, rapid adoption of portable and handheld systems coexists with strong investment in higher-end platforms in urban centers; supply chain strategies and local manufacturing considerations are particularly influential in this region. Across all regions, regulatory alignment, workforce training, and reimbursement clarity remain critical enablers for translating technology advancements into improved diagnostic workflows and expanded access.

Strategic company insights examining competitive positioning, partnership dynamics, R&D focus, and commercialization pathways among leading medical imaging firms

Competitive dynamics among companies operating in the breast ultrasound sector center on differentiation through integrated solutions, service excellence, and targeted clinical validation. Leading firms emphasize a blend of hardware innovation and software ecosystems, pursuing partnerships that combine advanced transducer design with AI-driven image analysis, cloud-enabled case management, and reporting standardization. Such alliances accelerate time-to-value for customers by reducing the integration burden and enabling clearer demonstration of clinical utility across diagnostic and interventional applications.

Commercial strategies increasingly prioritize lifecycle engagement rather than one-time device sales. Companies that bundle installation, tailored training, and outcome-oriented service contracts secure stronger long-term relationships with health systems. At the same time, mid-sized and emerging vendors often compete on niche features such as specialized probes or workflow-optimized handheld units, leveraging agility to enter underserved segments. Research and development investments focus on probe miniaturization, signal processing improvements, and user interfaces that reduce operator dependence. Strategic M&A and distribution agreements remain active levers to accelerate geographical expansion and fill product portfolio gaps, while companies with robust local service networks gain an edge in markets where uptime and rapid technical support determine purchasing decisions.

Practical and prioritized recommendations for industry leaders to enhance device accessibility, clinical workflows, supplier resilience, and payer engagement

Industry leaders should adopt a pragmatic playbook that aligns technology selection with clinical goals, supply chain resilience, and sustainable cost management. First, prioritize procurement decisions that balance image quality with total lifecycle costs; this includes negotiating transparent service level agreements and ensuring spare parts and consumables are clearly specified to avoid downstream price volatility. Second, invest in standardized training and credentialing programs that accelerate user proficiency, reduce variability in exam performance, and support internal quality metrics tied to diagnostic yield. Third, diversify supplier relationships to mitigate tariff and logistics risks, creating contractual flexibility that enables rapid substitution or regional sourcing when disruptions occur.

Additionally, organizations should pilot AI and workflow automation in controlled settings to validate clinical impact and gain clinician buy-in before scaling. Engage payers early to document value pathways and explore reimbursement mechanisms that recognize time-savings, reductions in downstream procedures, or improved diagnostic triage. For manufacturers, offering modular upgrade paths, transparent maintenance models, and consumable bundles will increase appeal to capital-constrained buyers. Finally, embed cross-functional governance that includes clinical leaders, procurement, and biomedical engineering to ensure cohesive decision-making across acquisition, implementation, and ongoing performance monitoring. These combined actions will strengthen readiness for both technological evolution and policy-driven market shifts.

Transparent research methodology describing data sources, validation protocols, expert consultations, and analytic rigor applied to breast ultrasound analysis

The research methodology underpinning this analysis combined primary expert engagement with rigorous secondary validation, ensuring that conclusions reflect both frontline clinical experience and broader industry signals. Primary inputs included structured interviews with radiologists, sonographers, clinical engineering professionals, procurement leaders, and corporate strategists, which provided insights on device utilization, training gaps, and vendor performance. Secondary review encompassed peer-reviewed literature, public regulatory guidance, product technical documentation, and aggregated clinical trial outcomes to triangulate claims about diagnostic performance and technology maturation. Wherever possible, claims were corroborated across multiple independent sources to minimize single-source bias.

Analytic rigor was maintained through documented validation protocols, including cross-checks of terminology, classification consistency for products and transducers, and reconciliation of service and consumable categorizations. Expert consultations informed interpretation of regional regulatory nuances and payer dynamics. Limitations include variability in reporting standards across institutions and the rapidly evolving nature of software-enabled features, which can outpace published validation studies. To address these constraints, the methodology emphasizes transparent assumptions, source audits, and an iterative review cycle that prioritizes high-quality clinical evidence and operational realities when synthesizing recommendations.

Concluding synthesis of strategic implications for clinicians, administrators, and manufacturers aimed at improving diagnostic accuracy and patient outcomes

The collective analysis underscores that breast ultrasound is at an inflection point where technological advances, changing clinical pathways, and external policy forces converge to reshape adoption and procurement behavior. Integrating AI, expanding the role of elastography and contrast techniques, and deploying portable modalities broaden the clinical utility of ultrasound while imposing new demands on training, validation, and service ecosystems. Concurrent policy and tariff pressures further influence sourcing strategies and cost structures, prompting stakeholders to adopt more agile procurement and supplier management practices.

For clinicians, the primary implication is a renewed focus on standardized acquisition protocols, quality assurance, and multidisciplinary collaboration to realize the diagnostic benefits of new technologies. For administrators and purchasers, emphasis should be on negotiating flexible contracts that account for consumable flows, maintenance needs, and potential tariff-related cost pressures. For manufacturers, success depends on delivering interoperable hardware-software ecosystems, demonstrable clinical value, and reliable service networks. By aligning technology choices with operational capacity and evidence-based clinical goals, stakeholders can improve diagnostic accuracy, streamline workflows, and ultimately enhance patient care outcomes across diverse care settings.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Adoption of contrast-enhanced ultrasound techniques to improve characterization of breast lesions
  • 5.2. Rising utilization of automated breast ultrasound systems to enhance screening sensitivity in dense breast tissue
  • 5.3. Advancements in elastography integrated into ultrasound devices for more accurate assessment of tissue stiffness in breast imaging
  • 5.4. Increasing demand for portable and handheld breast ultrasound scanners for point-of-care diagnostics in outpatient settings
  • 5.5. Development of AI-driven risk stratification tools combining clinical data with ultrasound imaging metrics for personalized breast cancer screening
  • 5.6. Expansion of tele-ultrasound services enabling remote interpretation and collaboration among specialists for breast cancer diagnosis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Breast Ultrasound Market, by Product

  • 8.1. Accessories & Consumables
    • 8.1.1. Gel
    • 8.1.2. Sterile Covers
  • 8.2. Equipment
    • 8.2.1. Probes
    • 8.2.2. Systems
  • 8.3. Services
    • 8.3.1. Installation
    • 8.3.2. Maintenance
    • 8.3.3. Training

9. Breast Ultrasound Market, by Modality

  • 9.1. Cart/Trolley
    • 9.1.1. Portable Cart
    • 9.1.2. Trolley Mounted
  • 9.2. Handheld
    • 9.2.1. Battery Powered
    • 9.2.2. Tethered

10. Breast Ultrasound Market, by Technology

  • 10.1. 2D Ultrasound
  • 10.2. 3D/4D Ultrasound
  • 10.3. Doppler Ultrasound
  • 10.4. Elastography

11. Breast Ultrasound Market, by Transducer Type

  • 11.1. 3D Transducer
  • 11.2. Curved Array
  • 11.3. Linear Array
  • 11.4. Phased Array

12. Breast Ultrasound Market, by Application

  • 12.1. Diagnostic
    • 12.1.1. Lesion Characterization
    • 12.1.2. Screening
    • 12.1.3. Staging
  • 12.2. Interventional
    • 12.2.1. Aspiration
    • 12.2.2. Biopsy Guidance
    • 12.2.3. Drainage

13. Breast Ultrasound Market, by End User

  • 13.1. Ambulatory Surgical Centers
  • 13.2. Clinics
  • 13.3. Diagnostic Imaging Centers
  • 13.4. Hospitals

14. Breast Ultrasound Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Breast Ultrasound Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Breast Ultrasound Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. GE HealthCare Technologies Inc.
    • 17.3.2. Siemens Healthineers AG
    • 17.3.3. Koninklijke Philips N.V.
    • 17.3.4. Hologic, Inc.
    • 17.3.5. Canon Medical Systems Corporation
    • 17.3.6. Samsung Medison Co., Ltd.
    • 17.3.7. Fujifilm Holdings Corporation
    • 17.3.8. Hitachi, Ltd.
    • 17.3.9. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • 17.3.10. Shenzhen SonoScape Medical Corp.

LIST OF FIGURES

  • FIGURE 1. GLOBAL BREAST ULTRASOUND MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY PRODUCT, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY MODALITY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY MODALITY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY TRANSDUCER TYPE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY TRANSDUCER TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS BREAST ULTRASOUND MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA BREAST ULTRASOUND MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA BREAST ULTRASOUND MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BREAST ULTRASOUND MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE BREAST ULTRASOUND MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST BREAST ULTRASOUND MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA BREAST ULTRASOUND MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC BREAST ULTRASOUND MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN BREAST ULTRASOUND MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC BREAST ULTRASOUND MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION BREAST ULTRASOUND MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS BREAST ULTRASOUND MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 BREAST ULTRASOUND MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO BREAST ULTRASOUND MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. BREAST ULTRASOUND MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. BREAST ULTRASOUND MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BREAST ULTRASOUND MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BREAST ULTRASOUND MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BREAST ULTRASOUND MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY ACCESSORIES & CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY ACCESSORIES & CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY ACCESSORIES & CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY ACCESSORIES & CONSUMABLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY ACCESSORIES & CONSUMABLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY ACCESSORIES & CONSUMABLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY ACCESSORIES & CONSUMABLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY ACCESSORIES & CONSUMABLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY GEL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY GEL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY GEL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY GEL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY GEL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY GEL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY STERILE COVERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY STERILE COVERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY STERILE COVERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY STERILE COVERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY STERILE COVERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY STERILE COVERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY EQUIPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY EQUIPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY EQUIPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY EQUIPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY EQUIPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY PROBES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY PROBES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY PROBES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY PROBES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY PROBES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY PROBES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY INSTALLATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY INSTALLATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY INSTALLATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY INSTALLATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY INSTALLATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY INSTALLATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY MAINTENANCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY MAINTENANCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY MAINTENANCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY MAINTENANCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY MAINTENANCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY MAINTENANCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY TRAINING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY TRAINING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY TRAINING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY TRAINING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY TRAINING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY TRAINING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY CART/TROLLEY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY CART/TROLLEY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY CART/TROLLEY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY CART/TROLLEY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY CART/TROLLEY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY CART/TROLLEY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY CART/TROLLEY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY CART/TROLLEY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY PORTABLE CART, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY PORTABLE CART, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY PORTABLE CART, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY PORTABLE CART, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY PORTABLE CART, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY PORTABLE CART, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY TROLLEY MOUNTED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY TROLLEY MOUNTED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY TROLLEY MOUNTED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY TROLLEY MOUNTED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY TROLLEY MOUNTED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY TROLLEY MOUNTED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY HANDHELD, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY HANDHELD, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY HANDHELD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY HANDHELD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY HANDHELD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY HANDHELD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY HANDHELD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY HANDHELD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY BATTERY POWERED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY BATTERY POWERED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY BATTERY POWERED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY BATTERY POWERED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY BATTERY POWERED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY BATTERY POWERED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY TETHERED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY TETHERED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY TETHERED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY TETHERED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY TETHERED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY TETHERED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY 2D ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY 2D ULTRASOUND, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY 2D ULTRASOUND, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY 2D ULTRASOUND, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY 2D ULTRASOUND, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY 2D ULTRASOUND, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY 3D/4D ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY 3D/4D ULTRASOUND, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY 3D/4D ULTRASOUND, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY 3D/4D ULTRASOUND, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY 3D/4D ULTRASOUND, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY 3D/4D ULTRASOUND, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY DOPPLER ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY DOPPLER ULTRASOUND, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY DOPPLER ULTRASOUND, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY DOPPLER ULTRASOUND, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY DOPPLER ULTRASOUND, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY DOPPLER ULTRASOUND, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY ELASTOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY ELASTOGRAPHY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY ELASTOGRAPHY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY ELASTOGRAPHY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY ELASTOGRAPHY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY ELASTOGRAPHY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY TRANSDUCER TYPE, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY TRANSDUCER TYPE, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY 3D TRANSDUCER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY 3D TRANSDUCER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY 3D TRANSDUCER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY 3D TRANSDUCER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY 3D TRANSDUCER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY 3D TRANSDUCER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY CURVED ARRAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY CURVED ARRAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY CURVED ARRAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY CURVED ARRAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY CURVED ARRAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY CURVED ARRAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY LINEAR ARRAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY LINEAR ARRAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY LINEAR ARRAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY LINEAR ARRAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY LINEAR ARRAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY LINEAR ARRAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY PHASED ARRAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY PHASED ARRAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY PHASED ARRAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY PHASED ARRAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY PHASED ARRAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY PHASED ARRAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY DIAGNOSTIC, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY DIAGNOSTIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY DIAGNOSTIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY DIAGNOSTIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY DIAGNOSTIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY LESION CHARACTERIZATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY LESION CHARACTERIZATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY LESION CHARACTERIZATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY LESION CHARACTERIZATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY LESION CHARACTERIZATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY LESION CHARACTERIZATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY SCREENING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY SCREENING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY SCREENING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY SCREENING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY SCREENING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY SCREENING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY STAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY STAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY STAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY STAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY STAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY STAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY INTERVENTIONAL, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY INTERVENTIONAL, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY INTERVENTIONAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY INTERVENTIONAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY INTERVENTIONAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY INTERVENTIONAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY INTERVENTIONAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY INTERVENTIONAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY ASPIRATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY ASPIRATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY ASPIRATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY ASPIRATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY ASPIRATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY ASPIRATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY BIOPSY GUIDANCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY BIOPSY GUIDANCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY BIOPSY GUIDANCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY BIOPSY GUIDANCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY BIOPSY GUIDANCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY BIOPSY GUIDANCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY DRAINAGE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY DRAINAGE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY DRAINAGE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY DRAINAGE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY DRAINAGE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY DRAINAGE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL BREAST ULTRASOUND MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 249. AMERICAS BREAST ULTRASOUND MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 250. AMERICAS BREAST ULTRASOUND MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 251. AMERICAS BREAST ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 252. AMERICAS BREAST ULTRASOUND MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 253. AMERICAS BREAST ULTRASOUND MARKET SIZE, BY ACCESSORIES & CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 254. AMERICAS BREAST ULTRASOUND MARKET SIZE, BY ACCESSORIES & CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 255. AMERICAS BREAST ULTRASOUND MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 256. AMERICAS BREAST ULTRASOUND MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 257. AMERICAS BREAST ULTRASOUND MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 258. AMERICAS BREAST ULTRASOUND MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 259. AMERICAS BREAST ULTRASOUND MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 260. AMERICAS BREAST ULTRASOUND MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 261. AMERICAS BREAST ULTRASOUND MARKET SIZE, BY CART/TROLLEY, 2018-2024 (USD MILLION)
  • TABLE 262. AMERICAS BREAST ULTRASOUND MARKET SIZE, BY CART/TROLLEY, 2025-2032 (USD MILLION)
  • TABLE 263. AMERICAS BREAST ULTRASOUND MARKET SIZE, BY HANDHELD, 2018-2024 (USD MILLION)
  • TABLE 264. AMERICAS BREAST ULTRASOUND MARKET SIZE, BY HANDHELD, 2025-2032 (USD MILLION)
  • TABLE 265. AMERICAS BREAST ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 266. AMERICAS BREAST ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 267. AMERICAS BREAST ULTRASOUND MARKET SIZE, BY TRANSDUCER TYPE, 2018-2024 (USD MILLION)
  • TABLE 268. AMERICAS BREAST ULTRASOUND MARKET SIZE, BY TRANSDUCER TYPE, 2025-2032 (USD MILLION)
  • TABLE 269. AMERICAS BREAST ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 270. AMERICAS BREAST ULTRASOUND MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 271. AMERICAS BREAST ULTRASOUND MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
  • TABLE 272. AMERICAS BREAST ULTRASOUND MARKET SIZE, BY DIAGNOSTIC, 2025-2032 (USD MILLION)
  • TABLE 273. AMERICAS BREAST ULTRASOUND MARKET SIZE, BY INTERVENTIONAL, 2018-2024 (USD MILLION)
  • TABLE 274. AMERICAS BREAST ULTRASOUND MARKET SIZE, BY INTERVENTIONAL, 2025-2032 (USD MILLION)
  • TABLE 275. AMERICAS BREAST ULTRASOUND MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 276. AMERICAS BREAST ULTRASOUND MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 277. NORTH AMERICA BREAST ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 278. NORTH AMERICA BREAST ULTRASOUND MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 279. NORTH AMERICA BREAST ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 280. NORTH AMERICA BREAST ULTRASOUND MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 281. NORTH AMERICA BREAST ULTRASOUND MARKET SIZE, BY ACCESSORIES & CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 282. NORTH AMERICA BREAST ULTRASOUND MARKET SIZE, BY ACCESSORIES & CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 283. NORTH AMERICA BREAST ULTRASOUND MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 284. NORTH AMERICA BREAST ULTRASOUND MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 285. NORTH AMERICA BREAST ULTRASOUND MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 286. NORTH AMERICA BREAST ULTRASOUND MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 287. NORTH AMERICA BREAST ULTRASOUND MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 288. NORTH AMERICA BREAST ULTRASOUND MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 289. NORTH AMERICA BREAST ULTRASOUND MARKET SIZE, BY CART/TROLLEY, 2018-2024 (USD MILLION)
  • TABLE 290. NORTH AMERICA BREAST ULTRASOUND MARKET SIZE, BY CART/TROLLEY, 2025-2032 (USD MILLION)
  • TABLE 291. NORTH AMERICA BREAST ULTRASOUND MARKET SIZE, BY HANDHELD, 2018-2024 (USD MILLION)
  • TABLE 292. NORTH AMERICA BREAST ULTRASOUND MARKET SIZE, BY HANDHELD, 2025-2032 (USD MILLION)
  • TABLE 293. NORTH AMERICA BREAST ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 294. NORTH AMERICA BREAST ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 295. NORTH AMERICA BREAST ULTRASOUND MARKET SIZE, BY TRANSDUCER TYPE, 2018-2024 (USD MILLION)
  • TABLE 296. NORTH AMERICA BREAST ULTRASOUND MARKET SIZE, BY TRANSDUCER TYPE, 2025-2032 (USD MILLION)
  • TABLE 297. NORTH AMERICA BREAST ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 298. NORTH AMERICA BREAST ULTRASOUND MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 299. NORTH AMERICA BREAST ULTRASOUND MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
  • TABLE 300. NORTH AMERICA BREAST ULTRASOUND MARKET SIZE, BY DIAGNOSTIC, 2025-2032 (USD MILLION)
  • TABLE 301. NORTH AMERICA BREAST ULTRASOUND MARKET SIZE, BY INTERVENTIONAL, 2018-2024 (USD MILLION)
  • TABLE 302. NORTH AMERICA BREAST ULTRASOUND MARKET SIZE, BY INTERVENTIONAL, 2025-2032 (USD MILLION)
  • TABLE 303. NORTH AMERICA BREAST ULTRASOUND MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 304. NORTH AMERICA BREAST ULTRASOUND MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 305. LATIN AMERICA BREAST ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 306. LATIN AMERICA BREAST ULTRASOUND MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 307. LATIN AMERICA BREAST ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 308. LATIN AMERICA BREAST ULTRASOUND MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 309. LATIN AMERICA BREAST ULTRASOUND MARKET SIZE, BY ACCESSORIES & CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 310. LATIN AMERICA BREAST ULTRASOUND MARKET SIZE, BY ACCESSORIES & CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 311. LATIN AMERICA BREAST ULTRASOUND MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 312. LATIN AMERICA BREAST ULTRASOUND MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 313. LATIN AMERICA BREAST ULTRASOUND MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 314. LATIN AMERICA BREAST ULTRASOUND MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 315. LATIN AMERICA BREAST ULTRASOUND MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 316. LATIN AMERICA BREAST ULTRASOUND MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 317. LATIN AMERICA BREAST ULTRASOUND MARKET SIZE, BY CART/TROLLEY, 2018-2024 (USD MILLION)
  • TABLE 318. LATIN AMERICA BREAST ULTRASOUND MARKET SIZE, BY CART/TROLLEY, 2025-2032 (USD MILLION)
  • TABLE 319. LATIN AMERICA BREAST ULTRASOUND MARKET SIZE, BY HANDHELD, 2018-2024 (USD MILLION)
  • TABLE 320. LATIN AMERICA BREAST ULTRASOUND MARKET SIZE, BY HANDHELD, 2025-2032 (USD MILLION)
  • TABLE 321. LATIN AMERICA BREAST ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 322. LATIN AMERICA BREAST ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 323. LATIN AMERICA BREAST ULTRASOUND MARKET SIZE, BY TRANSDUCER TYPE, 2018-2024 (USD MILLION)
  • TABLE 324. LATIN AMERICA BREAST ULTRASOUND MARKET SIZE, BY TRANSDUCER TYPE, 2025-2032 (USD MILLION)
  • TABLE 325. LATIN AMERICA BREAST ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 326. LATIN AMERICA BREAST ULTRASOUND MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 327. LATIN AMERICA BREAST ULTRASOUND MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
  • TABLE 328. LATIN AMERICA BREAST ULTRASOUND MARKET SIZE, BY DIAGNOSTIC, 2025-2032 (USD MILLION)
  • TABLE 329. LATIN AMERICA BREAST ULTRASOUND MARKET SIZE, BY INTERVENTIONAL, 2018-2024 (USD MILLION)
  • TABLE 330. LATIN AMERICA BREAST ULTRASOUND MARKET SIZE, BY INTERVENTIONAL, 2025-2032 (USD MILLION)
  • TABLE 331. LATIN AMERICA BREAST ULTRASOUND MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 332. LATIN AMERICA BREAST ULTRASOUND MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 333. EUROPE, MIDDLE EAST & AFRICA BREAST ULTRASOUND MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 334. EUROPE, MIDDLE EAST & AFRICA BREAST ULTRASOUND MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 335. EUROPE, MIDDLE EAST & AFRICA BREAST ULTRASOUND MARKET SIZE, BY PRODUCT, 2